Rosanna Santoro Selected Research

Anemia

2/2011

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosanna Santoro Research Topics

Disease

7	Fibrosis (Cirrhosis) 01/2019 - 01/2016
5	Infections 01/2019 - 01/2011
2	Chronic Hepatitis B 11/2019 - 01/2018
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 07/2002
2	Chronic Hepatitis C 01/2019 - 07/2002
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Portal Hypertension 01/2019
1	Inflammation (Inflammations) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Hemorrhage 01/2016
1	Hemolytic Anemia 02/2011
1	Anemia 02/2011
1	Body Weight (Weight, Body) 06/2005
1	Hepatitis 07/2002

Drug/Important Bio-Agent (IBA)

7	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 07/2002
4	SofosbuvirIBA 01/2019 - 01/2017
3	velpatasvirIBA 01/2019 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2018 - 02/2011
2	InterferonsIBA 11/2019 - 07/2002
2	TabletsIBA 01/2019 - 01/2019
2	Hepatitis B e AntigensIBA 01/2019 - 01/2018
2	peginterferon alfa-2b (Pegintron)FDA Link 02/2011 - 06/2005
1	VaccinesIBA 01/2019
1	micaIBA 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	ProteomeIBA 01/2019
1	vesatolimodIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	daclatasvirIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	rice nuclear protein GT-2 (GT-2)IBA 01/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	Inosine TriphosphataseIBA 02/2011
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2011
1	Interferon-alpha (Interferon Alfa)IBA 07/2002

Therapy/Procedure

4	Therapeutics 11/2019 - 02/2011
1	Contraindications 01/2016
1	Duration of Therapy 08/2013
1	Drug Tapering 02/2011
1	Blood Transfusion (Blood Transfusions) 01/2011